Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of Glycopyrronium in Subjects With Axillary Hyperhydrosis

NCT02530281 is registered in ClinicalTrials.gov with Journey Medical Corporation as lead sponsor.

NCT NCT02530281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02530281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of Glycopyrronium in Subjects With Axillary Hyperhydrosis
Lead sponsor
Journey Medical Corporation
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2015
Completion date
March 31, 2016
Enrollment
344 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hyperhidrosis